Antares Pharma (ATRS) Misses Q3 EPS by 32c
Get Alerts ATRS Hot Sheet
Join SI Premium – FREE
Antares Pharma (NASDAQ: ATRS) reported Q3 EPS of ($0.32). Revenue for the quarter came in at $3.5 million.
For earnings history and earnings-related data on Antares Pharma (ATRS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
- Trump praises IBM CEO
- Venezuela oil export revenue rises 21.5% in first quarter
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share